$2.00
+0 (+0%)
At Close: Aug 10, 2026
Diaceutics Earnings Calls
Jun 30, 2026
(Upcoming)
| Release date | Sep 29, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 20.12% |
Dec 31, 2025
$0.0418 (-30.65%)
| Release date | Jan 15, 2026 |
| EPS estimate | $0.0602 |
| EPS actual | $0.0418 |
| EPS Surprise | -30.65% |
| Revenue estimate | 34.178M |
| Revenue actual | 32.333M |
| Revenue Surprise | -5.40% |
Jun 30, 2025
-$0.0390 (-3.28%)
| Release date | Sep 23, 2025 |
| EPS estimate | -$0.0378 |
| EPS actual | -$0.0390 |
| EPS Surprise | -3.28% |
| Revenue estimate | 20.043M |
| Revenue actual | 19.993M |
| Revenue Surprise | -0.247% |
Mar 30, 2025
| Release date | May 19, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Diaceutics
Below you can see how DIUXF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Mar 30, 2025
| Release date | May 19, 2025 |
| Price on release | $1.37 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 16, 2025 | $1.37 |
| Apr 17, 2025 | $1.37 |
| Apr 21, 2025 | $1.37 |
| Apr 22, 2025 | $1.37 |
| Apr 23, 2025 | $1.37 |
| Jun 13, 2025 | $1.37 |
| Jun 19, 2025 | $1.37 |
| Jun 20, 2025 | $1.37 |
| Jun 23, 2025 | $1.37 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Jun 30, 2025
Missed
| Release date | Sep 23, 2025 |
| Price on release | $1.37 |
| EPS estimate | -$0.0378 |
| EPS actual | -$0.0390 |
| EPS surprise | -3.28% |
| Date | Price |
|---|---|
| Sep 17, 2025 | $1.37 |
| Sep 18, 2025 | $1.37 |
| Sep 19, 2025 | $1.37 |
| Sep 22, 2025 | $1.37 |
| Sep 23, 2025 | $1.37 |
| Sep 24, 2025 | $1.37 |
| Sep 25, 2025 | $1.37 |
| Sep 26, 2025 | $1.37 |
| Sep 29, 2025 | $1.37 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Dec 31, 2025
Missed
| Release date | Jan 15, 2026 |
| Price on release | $1.67 |
| EPS estimate | $0.0602 |
| EPS actual | $0.0418 |
| EPS surprise | -30.65% |
| Date | Price |
|---|---|
| Jan 09, 2026 | $1.37 |
| Jan 12, 2026 | $1.37 |
| Jan 13, 2026 | $1.37 |
| Jan 14, 2026 | $1.37 |
| Jan 15, 2026 | $1.67 |
| Jan 16, 2026 | $1.67 |
| Jan 20, 2026 | $1.67 |
| Jan 21, 2026 | $1.67 |
| Jan 22, 2026 | $1.67 |
| 4 days before | 22.15% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 22.15% |
Jun 30, 2026
(Upcoming)
| Release date | Sep 29, 2026 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $2.00 |
| Aug 05, 2026 | $2.00 |
| Aug 06, 2026 | $2.00 |
| Aug 07, 2026 | $2.00 |
| Aug 10, 2026 | $2.00 |
Diaceutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for DIUXF?
Diaceutics Plc (DIUXF) has scheduled its earnings report for Sep 29, 2026 after the markets close.
What is the DIUXF price-to-earnings (P/E) ratio?
DIUXF P/E ratio as of Aug 10, 2026 (TTM) is 1,381.82.
What is the DIUXF EPS forecast?
The forecasted EPS (Earnings Per Share) for Diaceutics Plc (DIUXF) for the first fiscal quarter 2026 is $.
What are Diaceutics Plc's retained earnings?
On its balance sheet, Diaceutics Plc reported retained earnings of $32.33 million for the latest quarter ending Dec 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Sign In
Buy DIUXF